drugset / Trial / NCT01445639

Dexmedetomidine in Patients After Intracranial Surgery

NCT01445639 ↗

Phase 4 Completed 192 enrolled Capital Medical University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Dexmedetomidine is a highly selective a2-adrenoreceptor agonist that produces dose-dependent sedation and analgesia without respiratory depression. Dexmedetomidine has been used in critically ill medical, surgical, and pediatric patients. No study has been designed specifically to evaluate dexmedetomidine uses in the neurocritical care population. The primary objective is to evaluate the safety and efficacy of dexmedetomidine for prophylactic analgesia and sedation in patients after intracranial surgery.

Timeline

Start
2011-10
Primary completion
2012-12
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg Intravenous